LogicBio Therapeutics, Inc. Operating Expenses
LogicBio Therapeutics, Inc. reported Operating Expenses of $8.46 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2022-11-14
- LogicBio Therapeutics, Inc. operating expenses for the quarter ending 2022-09-30 was $8.46M, a 29.86% decline year-over-year.
- LogicBio Therapeutics, Inc. operating expenses for the quarter ending 2022-06-30 was $8.09M, a 26.59% decline year-over-year.
- LogicBio Therapeutics, Inc. operating expenses for the quarter ending 2022-03-31 was $9.27M, a 11.58% decline year-over-year.
- LogicBio Therapeutics, Inc. operating expenses for the quarter ending 2021-12-31 was $10.83M, a 55.10% increase year-over-year.
- LogicBio Therapeutics, Inc. operating expenses for fiscal 2021 was $44.40M, a 26.97% increase from fiscal 2020.
- LogicBio Therapeutics, Inc. operating expenses for fiscal 2020 was $34.97M, a 14.80% decline from fiscal 2019.
- LogicBio Therapeutics, Inc. operating expenses for fiscal 2019 was $41.04M, a 128.73% increase from fiscal 2018.
- LogicBio Therapeutics, Inc. operating expenses for fiscal 2018 was $17.94M, a 206.51% increase from fiscal 2017.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2022-09-30 | $8.46M 10-Q · filed 2022-11-14 | $16.55M derived: sum of 2 quarters · filed 2022-11-14 | $25.82M 10-Q · filed 2022-11-14 | $36.65M derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | $8.09M 10-Q · filed 2022-08-15 | $17.36M 10-Q · filed 2022-08-15 | $28.19M derived: sum of 3 quarters · filed 2022-08-15 | $40.25M derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-03-31 | $9.27M 10-Q · filed 2022-05-16 | $20.10M derived: sum of 2 quarters · filed 2022-05-16 | $32.16M derived: sum of 3 quarters · filed 2022-11-14 | $43.18M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-12-31 | $10.83M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $22.89M derived: sum of 2 quarters · filed 2022-11-14 | $33.92M derived: sum of 3 quarters · filed 2022-11-14 | $44.40M 10-K · filed 2022-03-04 |
| 2021-09-30 | $12.06M 10-Q · filed 2022-11-14 | $23.09M derived: sum of 2 quarters · filed 2022-11-14 | $33.56M 10-Q · filed 2022-11-14 | $40.55M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $11.02M 10-Q · filed 2022-08-15 | $21.50M 10-Q · filed 2022-08-15 | $28.48M derived: sum of 3 quarters · filed 2022-08-15 | $37.18M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $10.48M 10-Q · filed 2022-05-16 | $17.46M derived: sum of 2 quarters · filed 2022-05-16 | $26.15M derived: sum of 3 quarters · filed 2022-05-16 | $35.08M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $6.98M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $15.68M derived: sum of 2 quarters · filed 2022-03-04 | $24.60M derived: sum of 3 quarters · filed 2022-03-04 | $34.97M 10-K · filed 2022-03-04 |
| 2020-09-30 | $8.69M 10-Q · filed 2021-11-15 | $17.62M derived: sum of 2 quarters · filed 2021-11-15 | $27.98M 10-Q · filed 2021-11-15 | $39.41M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $8.92M 10-Q · filed 2021-08-09 | $19.29M 10-Q · filed 2021-08-09 | $30.72M derived: sum of 3 quarters · filed 2021-08-09 | $41.75M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $10.37M 10-Q · filed 2021-05-10 | $21.80M derived: sum of 2 quarters · filed 2021-05-10 | $32.83M derived: sum of 3 quarters · filed 2021-05-10 | $43.29M derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $11.43M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $22.46M derived: sum of 2 quarters · filed 2021-03-15 | $32.92M derived: sum of 3 quarters · filed 2021-03-15 | $41.04M 10-K · filed 2021-03-15 |
| 2019-09-30 | $11.03M 10-Q · filed 2020-11-09 | $21.49M derived: sum of 2 quarters · filed 2020-11-09 | $29.61M 10-Q · filed 2020-11-09 | $36.99M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $10.46M 10-Q · filed 2020-08-10 | $18.58M 10-Q · filed 2020-08-10 | $25.95M derived: sum of 3 quarters · filed 2020-08-10 | $30.50M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $8.12M 10-Q · filed 2020-05-11 | $15.49M derived: sum of 2 quarters · filed 2020-05-11 | $20.05M derived: sum of 3 quarters · filed 2020-05-11 | $23.69M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $7.38M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $11.93M derived: sum of 2 quarters · filed 2020-03-16 | $15.57M derived: sum of 3 quarters · filed 2020-03-16 | $17.94M 10-K · filed 2020-03-16 |
| 2018-09-30 | $4.55M 10-Q · filed 2019-11-12 | $8.19M derived: sum of 2 quarters · filed 2019-11-12 | $10.57M 10-Q · filed 2019-11-12 | $13.65M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $3.64M 10-Q · filed 2019-08-13 | $6.01M 10-Q · filed 2019-08-13 | $9.10M derived: sum of 3 quarters · filed 2019-08-13 | $10.15M derived: sum of 4 quarters · filed 2019-08-13 |
| 2018-03-31 | $2.37M 10-Q · filed 2019-05-14 | $5.46M derived: sum of 2 quarters · filed 2019-05-14 | $6.51M derived: sum of 3 quarters · filed 2019-05-14 | |
| 2017-12-31 | $3.08M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $4.13M derived: sum of 2 quarters · filed 2019-04-01 | $5.85M 10-K · filed 2019-04-01 | |
| 2017-09-30 | $1.05M 10-Q · filed 2018-12-03 | $2.77M 10-Q · filed 2018-12-03 |